tiprankstipranks
Moleculin Biotech (MBRX)
NASDAQ:MBRX

Moleculin Biotech (MBRX) Financial Statements

1,328 Followers

Moleculin Biotech Financial Overview

Moleculin Biotech's market cap is currently ―. The company's EPS TTM is $-12.983; its P/E ratio is -0.27; Moleculin Biotech is scheduled to report earnings on August 14, 2024, and the estimated EPS forecast is $-2.51. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit---$ 12.00K$ -32.00K
EBIT$ -8.92M$ -5.95M$ -5.98M$ 8.79M$ -6.90M
EBITDA$ -8.88M$ -5.92M-$ 8.82M$ -6.86M
Net Income Common Stockholders$ -10.27M$ -5.61M$ -5.98M$ 8.79M$ -6.77M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 23.55M$ 24.58M$ 32.17M$ 37.27M$ 43.15M
Total Assets$ 38.22M$ 39.52M$ 47.12M$ 50.82M$ 57.42M
Total Debt$ 474.00K$ 496.00K$ 291.00K$ 308.00K$ 335.00K
Net Debt$ -23.08M$ -24.08M$ -31.88M$ -36.96M$ -42.81M
Total Liabilities$ 12.14M$ 4.38M$ 6.85M$ 5.39M$ 5.23M
Stockholders Equity$ 26.07M$ 35.14M$ 40.27M$ 45.68M$ 52.19M
Cash Flow-
Free Cash Flow$ -5.49M$ -7.58M-$ -6.02M$ -7.26M
Operating Cash Flow$ -5.41M$ -7.55M$ -5.13M$ -6.02M$ -7.26M
Investing Cash Flow$ -81.00K$ -28.00K$ -15.00K--
Financing Cash Flow$ 4.46M$ -4.00K$ 49.00K$ 141.00K-
Currency in USD

Moleculin Biotech Earnings and Revenue History

Moleculin Biotech Debt to Assets

Moleculin Biotech Cash Flow

Moleculin Biotech Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis